Lake Street Advisors Group LLC Sells 67 Shares of CME Group Inc. (NASDAQ:CME)

Lake Street Advisors Group LLC trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 0.5% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 12,407 shares of the financial services provider’s stock after selling 67 shares during the quarter. Lake Street Advisors Group LLC’s holdings in CME Group were worth $2,439,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CME. Vanguard Group Inc. boosted its position in shares of CME Group by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock valued at $7,044,821,000 after buying an additional 215,044 shares during the period. Capital International Investors lifted its stake in shares of CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after acquiring an additional 3,069,806 shares during the last quarter. Capital World Investors lifted its stake in shares of CME Group by 8.7% during the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after acquiring an additional 1,172,575 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in CME Group by 2.9% during the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock valued at $1,462,678,000 after acquiring an additional 189,842 shares during the period. Finally, Parnassus Investments LLC grew its position in CME Group by 0.4% in the 4th quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock valued at $1,193,551,000 after acquiring an additional 23,583 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CME shares. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Barclays boosted their price objective on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft raised their target price on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Keefe, Bruyette & Woods boosted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Finally, Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $212.00 to $177.00 in a research note on Tuesday. Four analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus price target of $209.73.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Up 0.5 %

Shares of NASDAQ CME opened at $220.50 on Friday. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $223.80. The stock’s fifty day simple moving average is $203.51 and its two-hundred day simple moving average is $207.61. The stock has a market capitalization of $79.39 billion, a PE ratio of 25.09, a price-to-earnings-growth ratio of 6.51 and a beta of 0.52. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same quarter last year, the company earned $2.30 earnings per share. As a group, analysts expect that CME Group Inc. will post 9.89 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.